ArticlePharmacoEconomics - open2024

Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.

Alexander Keenan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.